Yokohama City University Medical Center is a general hospital located in Minami-ku, Yokohama, Japan. Founded in 1871, it is the second oldest western-style hospital in Japan.

There are 726 beds in Yokohama City University Medical Center.

During the past decade, Yokohama City University Medical Center conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 10 clinical trials were completed, i.e. on average, 34.5% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 6 clinical trials were completed. i.e. 31.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yokohama City University Medical Center" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Boehringer Ingelheim" with 6 trials sponsored, "Yokohama City University" with 6 trials sponsored, "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yokohama City University Medical Center" #1 collaborator was "ASKA Pharmaceutical Co., Ltd." with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "EA Pharma Co., Ltd." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Yokohama City University Medical Center" are "Alzheimer Disease" (2 trials), "Carcinoma, Renal Cell" (2 trials), "Chronic Constipation" (2 trials), "Head and Neck Cancer" (2 trials) and "Nonalcoholic Fatty Liver" (2 trials). Many other conditions were trialed in "Yokohama City University Medical Center" in a lesser frequency.

Most popular intervention types in "Yokohama City University Medical Center" are "Drug" (36 trials), "Biological" (2 trials), "Device" (2 trials), "Radiation" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Atezolizumab" (8 trials), "Bevacizumab" (4 trials), "Elobixibat 10mg" (2 trials) and "bapineuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Yokohama City University Medical Center" are 35 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Yokohama City University Medical Center". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Yokohama City University Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Yokohama City University Medical Center, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".